Company page

Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. (Ticker: TRDA) is a public company based in the United States with a market capitalization of approximately $275.2 million. The company focuses on developing innovative therapies for patients with serious diseases. Its mission is to advance the field of medicine through groundbreaking research and development.